This study exists to understand whether the medication Lisdexamfetamine is both safe enough and useful enough to take further. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.
In United States
Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 55 Years
This study exists to explore whether the medication Quetiapine could improve care and understanding. Researchers are trying to understand whether the medication Quetiapine can better support energy, concentration, and everyday functioning.
This study exists to understand whether the medication HLD200 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication HLD200 in practice and what may need to be adjusted.
This study exists to see whether the medication OPC-14597 can make care clearer and more responsive. Researchers are trying to understand whether the medication OPC-14597 can better prevent setbacks and support longer-term stability.
In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Canada, Japan, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
This study exists to compare options and see whether the medication AVP-786 offers something meaningfully different. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
In United States
SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States, Bulgaria, Poland
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.